Douglas Bakan
Chief Tech/Sci/R&D Officer presso ARENA PHARMACEUTICALS
Profilo
Douglas A.
Bakan is currently the Vice President-Technical Operations at Arena Pharmaceuticals, Inc. Prior to this, he held positions such as Director-Product Development at Molecular Biosystems, Inc., Senior Director-Development at Neurocrine Biosciences, Inc., Manufacturing Director at Corvas International, Inc., Vice President-Product Development at Novalar Pharmaceuticals, Inc., Vice President-Business Development at Alerion Biomedical, Inc., and Chief Operating Officer at Metaprobe LLC.
Bakan received his undergraduate and doctorate degrees from the University of California San Diego.
Posizioni attive di Douglas Bakan
Società | Posizione | Inizio |
---|---|---|
ARENA PHARMACEUTICALS | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di Douglas Bakan
Società | Posizione | Fine |
---|---|---|
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Corvas International, Inc. | Corporate Officer/Principal | - |
Metaprobe LLC | Chief Operating Officer | - |
NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formazione di Douglas Bakan
University of California San Diego | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
Aziende private | 6 |
---|---|
Molecular Biosystems, Inc.
Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Health Technology |
Corvas International, Inc. | Health Technology |
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Health Technology |
Alerion Biomedical, Inc.
Alerion Biomedical, Inc. Medical SpecialtiesHealth Technology Alerion Biomedical, Inc. manufactures novel technologies for improving detection. It also manufactures biomarkers and contrast media for preclinical and clinical imaging devices. The company is headquartered in San Diego, CA. | Health Technology |
Metaprobe LLC |
- Borsa valori
- Insiders
- Douglas Bakan